

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 6.03619903 |
| 2 | drug catabolic process (GO:0042737) | 5.59889460 |
| 3 | regulation of protein activation cascade (GO:2000257) | 4.96653607 |
| 4 | regulation of fibrinolysis (GO:0051917) | 4.96066010 |
| 5 | negative regulation of fibrinolysis (GO:0051918) | 4.84521273 |
| 6 | cellular glucuronidation (GO:0052695) | 4.75655248 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 4.73825273 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 4.73825273 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.73825273 |
| 10 | regulation of complement activation (GO:0030449) | 4.66351229 |
| 11 | glucuronate metabolic process (GO:0019585) | 4.60333581 |
| 12 | uronic acid metabolic process (GO:0006063) | 4.60333581 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 4.58796812 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.51445159 |
| 15 | glyoxylate metabolic process (GO:0046487) | 4.46614608 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 4.45948124 |
| 17 | ribosomal small subunit assembly (GO:0000028) | 4.29299494 |
| 18 | S-adenosylmethionine metabolic process (GO:0046500) | 4.28522641 |
| 19 | omega-hydroxylase P450 pathway (GO:0097267) | 4.24226486 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.22908693 |
| 21 | negative regulation of protein activation cascade (GO:2000258) | 4.17243089 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 4.14586331 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.14586331 |
| 24 | complement activation, alternative pathway (GO:0006957) | 4.14309287 |
| 25 | bile acid metabolic process (GO:0008206) | 4.13848137 |
| 26 | oxidative demethylation (GO:0070989) | 4.09969346 |
| 27 | protein carboxylation (GO:0018214) | 3.96690318 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.96690318 |
| 29 | iron ion import (GO:0097286) | 3.95607746 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 3.87134417 |
| 31 | drug metabolic process (GO:0017144) | 3.86004390 |
| 32 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.84045207 |
| 33 | cysteine metabolic process (GO:0006534) | 3.81326460 |
| 34 | imidazole-containing compound metabolic process (GO:0052803) | 3.81199355 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78491198 |
| 36 | fibrinolysis (GO:0042730) | 3.77155200 |
| 37 | glycine metabolic process (GO:0006544) | 3.72888179 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.69657733 |
| 39 | L-phenylalanine metabolic process (GO:0006558) | 3.69657733 |
| 40 | indolalkylamine metabolic process (GO:0006586) | 3.66202345 |
| 41 | phospholipid efflux (GO:0033700) | 3.66187932 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 3.65846032 |
| 43 | negative regulation of sterol transport (GO:0032372) | 3.65846032 |
| 44 | intestinal cholesterol absorption (GO:0030299) | 3.65434370 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 3.62625915 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 3.62625915 |
| 47 | macromolecular complex remodeling (GO:0034367) | 3.62625915 |
| 48 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.60244087 |
| 49 | kynurenine metabolic process (GO:0070189) | 3.60088620 |
| 50 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.55972002 |
| 51 | low-density lipoprotein particle remodeling (GO:0034374) | 3.54835497 |
| 52 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.54559853 |
| 53 | urea metabolic process (GO:0019627) | 3.49397169 |
| 54 | cholesterol efflux (GO:0033344) | 3.48557950 |
| 55 | DNA strand elongation (GO:0022616) | 3.48292273 |
| 56 | triglyceride homeostasis (GO:0070328) | 3.47764939 |
| 57 | acylglycerol homeostasis (GO:0055090) | 3.47764939 |
| 58 | reverse cholesterol transport (GO:0043691) | 3.47743460 |
| 59 | tetrahydrofolate metabolic process (GO:0046653) | 3.45772962 |
| 60 | methionine biosynthetic process (GO:0009086) | 3.44181732 |
| 61 | bile acid and bile salt transport (GO:0015721) | 3.43432904 |
| 62 | maturation of SSU-rRNA (GO:0030490) | 3.42142508 |
| 63 | flavonoid metabolic process (GO:0009812) | 3.41663755 |
| 64 | negative regulation of complement activation (GO:0045916) | 3.41635155 |
| 65 | phospholipid homeostasis (GO:0055091) | 3.37357504 |
| 66 | telomere maintenance via recombination (GO:0000722) | 3.36983921 |
| 67 | heme transport (GO:0015886) | 3.35813892 |
| 68 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.35070630 |
| 69 | retinal metabolic process (GO:0042574) | 3.35062066 |
| 70 | IMP biosynthetic process (GO:0006188) | 3.33990513 |
| 71 | L-methionine biosynthetic process (GO:0071265) | 3.29210806 |
| 72 | amino acid salvage (GO:0043102) | 3.29210806 |
| 73 | L-methionine salvage (GO:0071267) | 3.29210806 |
| 74 | DNA deamination (GO:0045006) | 3.28762445 |
| 75 | blood coagulation, intrinsic pathway (GO:0007597) | 3.28346732 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.25371575 |
| 77 | DNA replication initiation (GO:0006270) | 3.24509949 |
| 78 | aromatic amino acid family metabolic process (GO:0009072) | 3.22959199 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 3.22028562 |
| 80 | DNA replication checkpoint (GO:0000076) | 3.21600021 |
| 81 | amino-acid betaine metabolic process (GO:0006577) | 3.20049075 |
| 82 | serine family amino acid catabolic process (GO:0009071) | 3.14563174 |
| 83 | purine nucleobase biosynthetic process (GO:0009113) | 3.13162155 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 3.13086042 |
| 85 | arginine metabolic process (GO:0006525) | 3.11841994 |
| 86 | sulfur amino acid biosynthetic process (GO:0000097) | 3.11477204 |
| 87 | mitotic recombination (GO:0006312) | 3.10497209 |
| 88 | benzene-containing compound metabolic process (GO:0042537) | 3.09917579 |
| 89 | drug transmembrane transport (GO:0006855) | 3.07475008 |
| 90 | plasma lipoprotein particle clearance (GO:0034381) | 3.07418032 |
| 91 | plasma lipoprotein particle organization (GO:0071827) | 3.07348683 |
| 92 | negative regulation of lipase activity (GO:0060192) | 3.06970493 |
| 93 | alpha-amino acid catabolic process (GO:1901606) | 3.05629549 |
| 94 | IMP metabolic process (GO:0046040) | 3.05241595 |
| 95 | nucleobase biosynthetic process (GO:0046112) | 3.04845525 |
| 96 | CENP-A containing nucleosome assembly (GO:0034080) | 3.01911797 |
| 97 | aspartate family amino acid biosynthetic process (GO:0009067) | 3.01242911 |
| 98 | regulation of cholesterol esterification (GO:0010872) | 2.99578211 |
| 99 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.97220727 |
| 100 | protein localization to kinetochore (GO:0034501) | 2.96957798 |
| 101 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.95857631 |
| 102 | ribosomal large subunit biogenesis (GO:0042273) | 2.95485249 |
| 103 | homocysteine metabolic process (GO:0050667) | 2.95250657 |
| 104 | kinetochore organization (GO:0051383) | 2.92790087 |
| 105 | xenobiotic catabolic process (GO:0042178) | 2.92160303 |
| 106 | chromatin remodeling at centromere (GO:0031055) | 2.91679959 |
| 107 | cellular ketone body metabolic process (GO:0046950) | 2.91672520 |
| 108 | regulation of triglyceride catabolic process (GO:0010896) | 2.90570402 |
| 109 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.90469023 |
| 110 | urea cycle (GO:0000050) | 2.89085401 |
| 111 | biotin metabolic process (GO:0006768) | 2.88910835 |
| 112 | telomere maintenance via telomere lengthening (GO:0010833) | 2.88712024 |
| 113 | phenylpropanoid metabolic process (GO:0009698) | 2.87630389 |
| 114 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.83875064 |
| 115 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.83474559 |
| 116 | mitotic metaphase plate congression (GO:0007080) | 2.83199223 |
| 117 | viral transcription (GO:0019083) | 2.82324912 |
| 118 | lipoprotein metabolic process (GO:0042157) | 2.81220690 |
| 119 | quinone metabolic process (GO:1901661) | 2.80771849 |
| 120 | ribosomal small subunit biogenesis (GO:0042274) | 2.80216023 |
| 121 | ethanol oxidation (GO:0006069) | 2.79892883 |
| 122 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.78707665 |
| 123 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.77901248 |
| 124 | kinetochore assembly (GO:0051382) | 2.77724334 |
| 125 | translational termination (GO:0006415) | 2.77000506 |
| 126 | ribosome biogenesis (GO:0042254) | 2.74882492 |
| 127 | protein localization to chromosome, centromeric region (GO:0071459) | 2.65969145 |
| 128 | ribosome assembly (GO:0042255) | 2.64848373 |
| 129 | formation of translation preinitiation complex (GO:0001731) | 2.62698624 |
| 130 | definitive hemopoiesis (GO:0060216) | 2.62068086 |
| 131 | immunoglobulin mediated immune response (GO:0016064) | 2.61392188 |
| 132 | proteasome assembly (GO:0043248) | 2.57091073 |
| 133 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.56935803 |
| 134 | B cell mediated immunity (GO:0019724) | 2.56535275 |
| 135 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.55131220 |
| 136 | DNA replication-independent nucleosome organization (GO:0034724) | 2.55131220 |
| 137 | replication fork processing (GO:0031297) | 2.54988932 |
| 138 | neutrophil activation involved in immune response (GO:0002283) | 2.54836150 |
| 139 | mitotic nuclear envelope disassembly (GO:0007077) | 2.53066695 |
| 140 | telomere maintenance (GO:0000723) | 2.52249506 |
| 141 | positive regulation of B cell differentiation (GO:0045579) | 2.52152105 |
| 142 | telomere organization (GO:0032200) | 2.50569890 |
| 143 | DNA unwinding involved in DNA replication (GO:0006268) | 2.50292473 |
| 144 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.49629870 |
| 145 | nuclear pore complex assembly (GO:0051292) | 2.48431657 |
| 146 | rRNA processing (GO:0006364) | 2.48090141 |
| 147 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.47392072 |
| 148 | pseudouridine synthesis (GO:0001522) | 2.46344551 |
| 149 | regulation of spindle organization (GO:0090224) | 2.45224293 |
| 150 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.44106533 |
| 151 | pinocytosis (GO:0006907) | 2.43225348 |
| 152 | metaphase plate congression (GO:0051310) | 2.42802293 |
| 153 | folic acid metabolic process (GO:0046655) | 2.42697133 |
| 154 | translational initiation (GO:0006413) | 2.41224829 |
| 155 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.41047283 |
| 156 | nuclear pore organization (GO:0006999) | 2.40155127 |
| 157 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.39995341 |
| 158 | rRNA metabolic process (GO:0016072) | 2.39821035 |
| 159 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.39432483 |
| 160 | daunorubicin metabolic process (GO:0044597) | 2.38822123 |
| 161 | polyketide metabolic process (GO:0030638) | 2.38822123 |
| 162 | doxorubicin metabolic process (GO:0044598) | 2.38822123 |
| 163 | translational elongation (GO:0006414) | 2.38457715 |
| 164 | response to interferon-beta (GO:0035456) | 2.33921588 |
| 165 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.33048309 |
| 166 | pore complex assembly (GO:0046931) | 2.30179288 |
| 167 | cotranslational protein targeting to membrane (GO:0006613) | 2.29877389 |
| 168 | protein targeting to ER (GO:0045047) | 2.29071630 |
| 169 | response to peptidoglycan (GO:0032494) | 2.28967908 |
| 170 | protein K6-linked ubiquitination (GO:0085020) | 2.28331278 |
| 171 | positive regulation of interferon-alpha production (GO:0032727) | 2.28312111 |
| 172 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.27285099 |
| 173 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.26432928 |
| 174 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.26432928 |
| 175 | modulation by symbiont of host immune response (GO:0052553) | 2.26432928 |
| 176 | positive regulation by symbiont of host defense response (GO:0052509) | 2.26432928 |
| 177 | modulation by symbiont of host defense response (GO:0052031) | 2.26432928 |
| 178 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.26432928 |
| 179 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.26084518 |
| 180 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.24413330 |
| 181 | meiotic chromosome segregation (GO:0045132) | 2.22854740 |
| 182 | tRNA methylation (GO:0030488) | 2.21551939 |
| 183 | nuclear envelope disassembly (GO:0051081) | 2.20884178 |
| 184 | membrane disassembly (GO:0030397) | 2.20884178 |
| 185 | RNA-dependent DNA replication (GO:0006278) | 2.19251653 |
| 186 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.18937565 |
| 187 | establishment of chromosome localization (GO:0051303) | 2.18813217 |
| 188 | response to interferon-alpha (GO:0035455) | 2.17626946 |
| 189 | protein localization to endoplasmic reticulum (GO:0070972) | 2.15805975 |
| 190 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.15312903 |
| 191 | histone exchange (GO:0043486) | 2.15010050 |
| 192 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.13758339 |
| 193 | regulation of interferon-alpha production (GO:0032647) | 2.13564265 |
| 194 | neutrophil mediated immunity (GO:0002446) | 2.11775991 |
| 195 | positive regulation of interferon-beta production (GO:0032728) | 2.11720940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.95185321 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.73969025 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.26818025 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.19320396 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.10436844 |
| 6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.98872668 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.79351357 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.63288423 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.58528408 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45602064 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.38338100 |
| 12 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34344783 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.33061067 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24939950 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.24388244 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.23404407 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.21132591 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18758282 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.15955328 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.12558048 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.12482423 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.09379735 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.07265546 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 2.06279189 |
| 25 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.05795936 |
| 26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.04938238 |
| 27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.01399217 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.99073550 |
| 29 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.95938412 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95304690 |
| 31 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.94720225 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88916139 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.88070528 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82072756 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81271516 |
| 36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.81022310 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79743583 |
| 38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.78097217 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.77494715 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76019364 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75098246 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74511113 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74104879 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73846627 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73678970 |
| 46 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.72893940 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66019350 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.65678765 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.65143562 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62597932 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61424630 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60634606 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.60469444 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.59382356 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54835991 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53762931 |
| 57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53554728 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.51715461 |
| 59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50824426 |
| 60 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.49599774 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49072505 |
| 62 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47529763 |
| 63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.47309429 |
| 64 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46596910 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.45644456 |
| 66 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.45398448 |
| 67 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44089431 |
| 68 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42896574 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.41405269 |
| 70 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.40830589 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40036776 |
| 72 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.39399642 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38064443 |
| 74 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36286968 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.36176565 |
| 76 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.36076241 |
| 77 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.35713629 |
| 78 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35296331 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.33894188 |
| 80 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.33392617 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33224865 |
| 82 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.30988804 |
| 83 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.30056922 |
| 84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29675391 |
| 85 | MYC_22102868_ChIP-Seq_BL_Human | 1.29478026 |
| 86 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.29225812 |
| 87 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29169117 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29066032 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28389369 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.27518682 |
| 91 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27404475 |
| 92 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27082367 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25272671 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24566156 |
| 95 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.24373567 |
| 96 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23940736 |
| 97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23703445 |
| 98 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.20857445 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20777292 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20755736 |
| 101 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.20721470 |
| 102 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20158285 |
| 103 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19520351 |
| 104 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.18107452 |
| 105 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18014304 |
| 106 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.17889737 |
| 107 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17600222 |
| 108 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.16746102 |
| 109 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.16489037 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16487771 |
| 111 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.16066765 |
| 112 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15964667 |
| 113 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14651229 |
| 114 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13848505 |
| 115 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13087795 |
| 116 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13087795 |
| 117 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12888972 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12773140 |
| 119 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.12683481 |
| 120 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12555624 |
| 121 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 1.12418089 |
| 122 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.11509627 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11137441 |
| 124 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.10683590 |
| 125 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.10597429 |
| 126 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10331304 |
| 127 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10159498 |
| 128 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09948780 |
| 129 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08629482 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08532803 |
| 131 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 1.08283700 |
| 132 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08138142 |
| 133 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07693723 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07511741 |
| 135 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06789289 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06781317 |
| 137 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06603629 |
| 138 | MYB_26560356_Chip-Seq_TH1_Human | 1.06113017 |
| 139 | EWS_26573619_Chip-Seq_HEK293_Human | 1.06088152 |
| 140 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06048071 |
| 141 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.05806087 |
| 142 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05727408 |
| 143 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.05571501 |
| 144 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05129880 |
| 145 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.04559735 |
| 146 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.04189994 |
| 147 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01544834 |
| 148 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01544834 |
| 149 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.01182504 |
| 150 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.01182504 |
| 151 | MYB_26560356_Chip-Seq_TH2_Human | 1.01034947 |
| 152 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00130075 |
| 153 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.99320688 |
| 154 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.98747377 |
| 155 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98177185 |
| 156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98075708 |
| 157 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.97917597 |
| 158 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97775936 |
| 159 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.97364500 |
| 160 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.97165799 |
| 161 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97014107 |
| 162 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96196244 |
| 163 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95421620 |
| 164 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95374780 |
| 165 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.95156181 |
| 166 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.94913616 |
| 167 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.94591829 |
| 168 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94447858 |
| 169 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94412386 |
| 170 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94350407 |
| 171 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.94178061 |
| 172 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94022735 |
| 173 | MAF_26560356_Chip-Seq_TH1_Human | 0.93893209 |
| 174 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.93685742 |
| 175 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92319149 |
| 176 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91057502 |
| 177 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90266757 |
| 178 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90102526 |
| 179 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.89702201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 4.45233860 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 4.33679269 |
| 3 | MP0005365_abnormal_bile_salt | 4.24020805 |
| 4 | MP0003252_abnormal_bile_duct | 3.69761323 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.62737608 |
| 6 | MP0002396_abnormal_hematopoietic_system | 3.17032906 |
| 7 | MP0008057_abnormal_DNA_replication | 2.88892800 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.69213573 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.58037520 |
| 10 | MP0010094_abnormal_chromosome_stability | 2.55555737 |
| 11 | MP0001661_extended_life_span | 2.37903357 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.30291210 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.26202683 |
| 14 | MP0003077_abnormal_cell_cycle | 2.25761422 |
| 15 | MP0000490_abnormal_crypts_of | 2.19065033 |
| 16 | MP0008058_abnormal_DNA_repair | 2.17288134 |
| 17 | MP0001545_abnormal_hematopoietic_system | 2.13920011 |
| 18 | MP0005397_hematopoietic_system_phenotyp | 2.13920011 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.11883382 |
| 20 | MP0003436_decreased_susceptibility_to | 2.10005031 |
| 21 | MP0005174_abnormal_tail_pigmentation | 1.96509997 |
| 22 | MP0005408_hypopigmentation | 1.94987442 |
| 23 | MP0005332_abnormal_amino_acid | 1.94668431 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.92818323 |
| 25 | MP0003724_increased_susceptibility_to | 1.90932632 |
| 26 | MP0009785_altered_susceptibility_to | 1.87749839 |
| 27 | MP0008007_abnormal_cellular_replicative | 1.84040561 |
| 28 | MP0002419_abnormal_innate_immunity | 1.82888283 |
| 29 | MP0003868_abnormal_feces_composition | 1.81696104 |
| 30 | MP0005083_abnormal_biliary_tract | 1.78804058 |
| 31 | MP0000609_abnormal_liver_physiology | 1.78615072 |
| 32 | MP0005451_abnormal_body_composition | 1.74559960 |
| 33 | MP0005025_abnormal_response_to | 1.74152107 |
| 34 | MP0010307_abnormal_tumor_latency | 1.71581584 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.68989556 |
| 36 | MP0001853_heart_inflammation | 1.64993062 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.64552658 |
| 38 | MP0005075_abnormal_melanosome_morpholog | 1.58733160 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.58046952 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.56483600 |
| 41 | MP0000383_abnormal_hair_follicle | 1.56009272 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.55723729 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.55580138 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.54180387 |
| 45 | MP0001800_abnormal_humoral_immune | 1.54144813 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.52587995 |
| 47 | MP0005671_abnormal_response_to | 1.50946280 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.46682314 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.46242383 |
| 50 | MP0003186_abnormal_redox_activity | 1.45597845 |
| 51 | MP0002398_abnormal_bone_marrow | 1.45551021 |
| 52 | MP0002723_abnormal_immune_serum | 1.44825704 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.42928382 |
| 54 | MP0000858_altered_metastatic_potential | 1.38815180 |
| 55 | MP0009840_abnormal_foam_cell | 1.38797650 |
| 56 | MP0001819_abnormal_immune_cell | 1.38793497 |
| 57 | MP0009278_abnormal_bone_marrow | 1.38666830 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.38556205 |
| 59 | MP0002722_abnormal_immune_system | 1.37916618 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.31632550 |
| 61 | MP0010678_abnormal_skin_adnexa | 1.31587166 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.31580491 |
| 63 | MP0003786_premature_aging | 1.28582386 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 1.28178886 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 1.27322658 |
| 66 | MP0000716_abnormal_immune_system | 1.24494764 |
| 67 | MP0002429_abnormal_blood_cell | 1.23325221 |
| 68 | MP0006082_CNS_inflammation | 1.23077078 |
| 69 | MP0000685_abnormal_immune_system | 1.22996128 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.22925405 |
| 71 | MP0002006_tumorigenesis | 1.22173935 |
| 72 | MP0003890_abnormal_embryonic-extraembry | 1.22078880 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 1.21787638 |
| 74 | MP0003941_abnormal_skin_development | 1.21318482 |
| 75 | MP0002132_abnormal_respiratory_system | 1.20841080 |
| 76 | MP0003950_abnormal_plasma_membrane | 1.20276963 |
| 77 | MP0003763_abnormal_thymus_physiology | 1.20104892 |
| 78 | MP0002405_respiratory_system_inflammati | 1.18756255 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.18444813 |
| 80 | MP0002019_abnormal_tumor_incidence | 1.18397934 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.16841558 |
| 82 | MP0000015_abnormal_ear_pigmentation | 1.16626997 |
| 83 | MP0003718_maternal_effect | 1.14781780 |
| 84 | MP0002098_abnormal_vibrissa_morphology | 1.14097954 |
| 85 | MP0008469_abnormal_protein_level | 1.12998012 |
| 86 | MP0000427_abnormal_hair_cycle | 1.12436452 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 1.12259213 |
| 88 | MP0005551_abnormal_eye_electrophysiolog | 1.10678019 |
| 89 | MP0000350_abnormal_cell_proliferation | 1.10364744 |
| 90 | MP0005387_immune_system_phenotype | 1.09543619 |
| 91 | MP0001790_abnormal_immune_system | 1.09543619 |
| 92 | MP0000313_abnormal_cell_death | 1.09355138 |
| 93 | MP0003566_abnormal_cell_adhesion | 1.08778632 |
| 94 | MP0008932_abnormal_embryonic_tissue | 1.08666911 |
| 95 | MP0001873_stomach_inflammation | 1.06585297 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 1.05770364 |
| 97 | MP0008775_abnormal_heart_ventricle | 1.05314676 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03379507 |
| 99 | MP0003448_altered_tumor_morphology | 1.02489075 |
| 100 | MP0003303_peritoneal_inflammation | 1.01833601 |
| 101 | MP0008995_early_reproductive_senescence | 1.00719624 |
| 102 | MP0005395_other_phenotype | 0.98576870 |
| 103 | MP0004272_abnormal_basement_membrane | 0.97753829 |
| 104 | MP0004947_skin_inflammation | 0.97076191 |
| 105 | MP0002234_abnormal_pharynx_morphology | 0.96946907 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.96191423 |
| 107 | MP0000703_abnormal_thymus_morphology | 0.95821516 |
| 108 | MP0000647_abnormal_sebaceous_gland | 0.94999846 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.94515679 |
| 110 | MP0002095_abnormal_skin_pigmentation | 0.94411860 |
| 111 | MP0001764_abnormal_homeostasis | 0.93378831 |
| 112 | MP0000372_irregular_coat_pigmentation | 0.92681620 |
| 113 | MP0004147_increased_porphyrin_level | 0.91900158 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.91620430 |
| 115 | MP0002139_abnormal_hepatobiliary_system | 0.90730553 |
| 116 | MP0000343_altered_response_to | 0.90327666 |
| 117 | MP0009763_increased_sensitivity_to | 0.89874865 |
| 118 | MP0000371_diluted_coat_color | 0.87727770 |
| 119 | MP0005023_abnormal_wound_healing | 0.87353800 |
| 120 | MP0004019_abnormal_vitamin_homeostasis | 0.87229663 |
| 121 | MP0009697_abnormal_copulation | 0.86902294 |
| 122 | MP0003828_pulmonary_edema | 0.86124098 |
| 123 | MP0005376_homeostasis/metabolism_phenot | 0.85615489 |
| 124 | MP0009643_abnormal_urine_homeostasis | 0.85196681 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.83408252 |
| 126 | MP0002009_preneoplasia | 0.82789593 |
| 127 | MP0005360_urolithiasis | 0.82596643 |
| 128 | MP0001730_embryonic_growth_arrest | 0.82281650 |
| 129 | MP0005220_abnormal_exocrine_pancreas | 0.81542647 |
| 130 | MP0006054_spinal_hemorrhage | 0.80879144 |
| 131 | MP0000598_abnormal_liver_morphology | 0.80827163 |
| 132 | MP0009764_decreased_sensitivity_to | 0.80217497 |
| 133 | MP0003300_gastrointestinal_ulcer | 0.77807624 |
| 134 | MP0002282_abnormal_trachea_morphology | 0.75846823 |
| 135 | MP0005380_embryogenesis_phenotype | 0.75620111 |
| 136 | MP0001672_abnormal_embryogenesis/_devel | 0.75620111 |
| 137 | MP0002086_abnormal_extraembryonic_tissu | 0.75339580 |
| 138 | MP0005085_abnormal_gallbladder_physiolo | 0.75259824 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.74677450 |
| 140 | MP0002138_abnormal_hepatobiliary_system | 0.72684906 |
| 141 | MP0005275_abnormal_skin_tensile | 0.72334671 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.72105718 |
| 143 | MP0009115_abnormal_fat_cell | 0.71491393 |
| 144 | MP0001216_abnormal_epidermal_layer | 0.68729619 |
| 145 | MP0001915_intracranial_hemorrhage | 0.68599738 |
| 146 | MP0005647_abnormal_sex_gland | 0.67299276 |
| 147 | MP0006036_abnormal_mitochondrial_physio | 0.66480653 |
| 148 | MP0005410_abnormal_fertilization | 0.65198984 |
| 149 | MP0000467_abnormal_esophagus_morphology | 0.64590301 |
| 150 | MP0002254_reproductive_system_inflammat | 0.63863213 |
| 151 | MP0000358_abnormal_cell_content/ | 0.63813292 |
| 152 | MP0005187_abnormal_penis_morphology | 0.62575854 |
| 153 | MP0004043_abnormal_pH_regulation | 0.59037761 |
| 154 | MP0009642_abnormal_blood_homeostasis | 0.58895896 |
| 155 | MP0008872_abnormal_physiological_respon | 0.58881027 |
| 156 | MP0005334_abnormal_fat_pad | 0.58867870 |
| 157 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58844945 |
| 158 | MP0003943_abnormal_hepatobiliary_system | 0.58539113 |
| 159 | MP0001929_abnormal_gametogenesis | 0.58363705 |
| 160 | MP0005501_abnormal_skin_physiology | 0.57931002 |
| 161 | MP0005164_abnormal_response_to | 0.55346930 |
| 162 | MP0005253_abnormal_eye_physiology | 0.55045489 |
| 163 | MP0003646_muscle_fatigue | 0.54211782 |
| 164 | MP0002090_abnormal_vision | 0.54058934 |
| 165 | MP0002796_impaired_skin_barrier | 0.52981928 |
| 166 | MP0005266_abnormal_metabolism | 0.51720681 |
| 167 | MP0005389_reproductive_system_phenotype | 0.51579265 |
| 168 | MP0002168_other_aberrant_phenotype | 0.50949789 |
| 169 | MP0002971_abnormal_brown_adipose | 0.50474862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 5.44903690 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 5.37900098 |
| 3 | Conjugated hyperbilirubinemia (HP:0002908) | 4.85932112 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.64363533 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.42970919 |
| 6 | Complement deficiency (HP:0004431) | 3.98830964 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.84969515 |
| 8 | Chromsome breakage (HP:0040012) | 3.84213853 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 3.74506386 |
| 10 | Poikilocytosis (HP:0004447) | 3.73311054 |
| 11 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.70155638 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.68098301 |
| 13 | Reticulocytopenia (HP:0001896) | 3.58016562 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.47605396 |
| 15 | Acanthocytosis (HP:0001927) | 3.43969790 |
| 16 | Spontaneous abortion (HP:0005268) | 3.42091601 |
| 17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.41478450 |
| 18 | Epidermoid cyst (HP:0200040) | 3.33126833 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.27817958 |
| 20 | Abnormal number of erythroid precursors (HP:0012131) | 3.25261545 |
| 21 | Thrombocytosis (HP:0001894) | 3.21294477 |
| 22 | Reduced antithrombin III activity (HP:0001976) | 3.18600129 |
| 23 | Generalized aminoaciduria (HP:0002909) | 3.16647300 |
| 24 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.15147925 |
| 25 | Aplastic anemia (HP:0001915) | 3.11507209 |
| 26 | Xanthomatosis (HP:0000991) | 3.05994833 |
| 27 | Petechiae (HP:0000967) | 3.01020258 |
| 28 | Prolonged bleeding time (HP:0003010) | 2.98352124 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 2.94689256 |
| 30 | Abnormality of chromosome stability (HP:0003220) | 2.89293409 |
| 31 | Abnormality of the preputium (HP:0100587) | 2.85581409 |
| 32 | Eczematoid dermatitis (HP:0000976) | 2.84539045 |
| 33 | Fair hair (HP:0002286) | 2.84013945 |
| 34 | Fat malabsorption (HP:0002630) | 2.78017311 |
| 35 | Myelodysplasia (HP:0002863) | 2.75939188 |
| 36 | Birth length less than 3rd percentile (HP:0003561) | 2.74922460 |
| 37 | Hyperglycinuria (HP:0003108) | 2.72368716 |
| 38 | Myositis (HP:0100614) | 2.72105555 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.68528706 |
| 40 | Agnosia (HP:0010524) | 2.68234580 |
| 41 | Renal cortical cysts (HP:0000803) | 2.66344508 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.66160809 |
| 43 | Abnormality of complement system (HP:0005339) | 2.64801550 |
| 44 | Pustule (HP:0200039) | 2.64273206 |
| 45 | Abnormality of the prostate (HP:0008775) | 2.64096638 |
| 46 | Abnormality of the renal cortex (HP:0011035) | 2.63281501 |
| 47 | Hyperammonemia (HP:0001987) | 2.62175336 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58213145 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.57716998 |
| 50 | Osteomalacia (HP:0002749) | 2.57199991 |
| 51 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.55608198 |
| 52 | Hyperbilirubinemia (HP:0002904) | 2.54569481 |
| 53 | Clubbing of toes (HP:0100760) | 2.52888902 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.52870403 |
| 55 | Prostate neoplasm (HP:0100787) | 2.52149441 |
| 56 | Periodontitis (HP:0000704) | 2.51854091 |
| 57 | Nausea (HP:0002018) | 2.51315227 |
| 58 | Bone marrow hypocellularity (HP:0005528) | 2.50940203 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50333008 |
| 60 | Epistaxis (HP:0000421) | 2.49001584 |
| 61 | Pallor (HP:0000980) | 2.46817075 |
| 62 | Oral leukoplakia (HP:0002745) | 2.45667820 |
| 63 | IgM deficiency (HP:0002850) | 2.42676973 |
| 64 | Meckel diverticulum (HP:0002245) | 2.42520588 |
| 65 | Hyperglycinemia (HP:0002154) | 2.40646529 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.36812488 |
| 67 | Impaired platelet aggregation (HP:0003540) | 2.33900328 |
| 68 | Abnormal platelet function (HP:0011869) | 2.33900328 |
| 69 | Hypophosphatemic rickets (HP:0004912) | 2.31928167 |
| 70 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.31862331 |
| 71 | Reticulocytosis (HP:0001923) | 2.31842356 |
| 72 | Obstructive lung disease (HP:0006536) | 2.30543825 |
| 73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30543825 |
| 74 | Mediastinal lymphadenopathy (HP:0100721) | 2.30044277 |
| 75 | Abnormality of the ileum (HP:0001549) | 2.29992798 |
| 76 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.29441770 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.29371177 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 2.27201181 |
| 79 | Cholecystitis (HP:0001082) | 2.27201181 |
| 80 | Orchitis (HP:0100796) | 2.26943371 |
| 81 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.24981176 |
| 82 | Rough bone trabeculation (HP:0100670) | 2.24403058 |
| 83 | Gingival bleeding (HP:0000225) | 2.24094118 |
| 84 | Hepatocellular carcinoma (HP:0001402) | 2.23040337 |
| 85 | Abnormality of glycine metabolism (HP:0010895) | 2.22723075 |
| 86 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.22723075 |
| 87 | Abnormality of nail color (HP:0100643) | 2.22259456 |
| 88 | Submucous cleft hard palate (HP:0000176) | 2.21247087 |
| 89 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.20539889 |
| 90 | Abnormality of urine glucose concentration (HP:0011016) | 2.19801716 |
| 91 | Glycosuria (HP:0003076) | 2.19801716 |
| 92 | Onycholysis (HP:0001806) | 2.18310811 |
| 93 | Increased serum pyruvate (HP:0003542) | 2.16861468 |
| 94 | Proximal tubulopathy (HP:0000114) | 2.16818557 |
| 95 | Glomerulonephritis (HP:0000099) | 2.15776865 |
| 96 | Abnormality of alanine metabolism (HP:0010916) | 2.13156259 |
| 97 | Hyperalaninemia (HP:0003348) | 2.13156259 |
| 98 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.13156259 |
| 99 | Right ventricular cardiomyopathy (HP:0011663) | 2.12034753 |
| 100 | Recurrent fungal infections (HP:0002841) | 2.11948886 |
| 101 | Steatorrhea (HP:0002570) | 2.11484459 |
| 102 | Arthropathy (HP:0003040) | 2.10779506 |
| 103 | Recurrent viral infections (HP:0004429) | 2.10340295 |
| 104 | Retrobulbar optic neuritis (HP:0100654) | 2.09619964 |
| 105 | Optic neuritis (HP:0100653) | 2.09619964 |
| 106 | Abnormal biliary tract physiology (HP:0012439) | 2.09501730 |
| 107 | Bile duct proliferation (HP:0001408) | 2.09501730 |
| 108 | Tubulointerstitial nephritis (HP:0001970) | 2.09065112 |
| 109 | Recurrent skin infections (HP:0001581) | 2.08386861 |
| 110 | Menorrhagia (HP:0000132) | 2.08046529 |
| 111 | Pancytopenia (HP:0001876) | 2.07551301 |
| 112 | Leukopenia (HP:0001882) | 2.07398745 |
| 113 | Macrocytic anemia (HP:0001972) | 2.06487553 |
| 114 | Azoospermia (HP:0000027) | 2.06439992 |
| 115 | Amaurosis fugax (HP:0100576) | 2.06243434 |
| 116 | Acute myeloid leukemia (HP:0004808) | 2.05891533 |
| 117 | Hypoglycemic coma (HP:0001325) | 2.05189218 |
| 118 | Abnormality of serum amino acid levels (HP:0003112) | 2.03280479 |
| 119 | Joint hemorrhage (HP:0005261) | 2.03038578 |
| 120 | Enlarged kidneys (HP:0000105) | 2.03001029 |
| 121 | Autoimmune thrombocytopenia (HP:0001973) | 2.00827916 |
| 122 | Impulsivity (HP:0100710) | 2.00624430 |
| 123 | Rickets (HP:0002748) | 2.00242463 |
| 124 | Pancreatic cysts (HP:0001737) | 2.00013678 |
| 125 | Abnormality of glycolysis (HP:0004366) | 1.99561643 |
| 126 | Gingivitis (HP:0000230) | 1.98224100 |
| 127 | Duplicated collecting system (HP:0000081) | 1.97781179 |
| 128 | Abnormal trabecular bone morphology (HP:0100671) | 1.97488287 |
| 129 | Plantar hyperkeratosis (HP:0007556) | 1.96822137 |
| 130 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.95674684 |
| 131 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95392314 |
| 132 | Absent thumb (HP:0009777) | 1.94956318 |
| 133 | Abnormality of lateral ventricle (HP:0030047) | 1.94479954 |
| 134 | Cheilitis (HP:0100825) | 1.94076972 |
| 135 | Abnormality of T cell physiology (HP:0011840) | 1.93885078 |
| 136 | Increased serum ferritin (HP:0003281) | 1.91845028 |
| 137 | Encephalitis (HP:0002383) | 1.91309560 |
| 138 | Duodenal stenosis (HP:0100867) | 1.90653565 |
| 139 | Small intestinal stenosis (HP:0012848) | 1.90653565 |
| 140 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.89131909 |
| 141 | Lymphoma (HP:0002665) | 1.88720549 |
| 142 | Metabolic acidosis (HP:0001942) | 1.88599943 |
| 143 | Ectropion (HP:0000656) | 1.88091583 |
| 144 | Anorexia (HP:0002039) | 1.87045315 |
| 145 | Abnormal platelet volume (HP:0011876) | 1.85325194 |
| 146 | Abnormality of DNA repair (HP:0003254) | 1.84407250 |
| 147 | Premature graying of hair (HP:0002216) | 1.84159426 |
| 148 | Granulocytopenia (HP:0001913) | 1.83890746 |
| 149 | Generalized hypopigmentation of hair (HP:0011358) | 1.83082447 |
| 150 | Hypoplastic labia majora (HP:0000059) | 1.82529668 |
| 151 | Basal ganglia calcification (HP:0002135) | 1.82055555 |
| 152 | Abnormality of reticulocytes (HP:0004312) | 1.82049824 |
| 153 | Hypochromic anemia (HP:0001931) | 1.81439243 |
| 154 | Abnormality of the anterior horn cell (HP:0006802) | 1.81268567 |
| 155 | Degeneration of anterior horn cells (HP:0002398) | 1.81268567 |
| 156 | Increased cerebral lipofuscin (HP:0011813) | 1.81113685 |
| 157 | Vascular calcification (HP:0004934) | 1.79054304 |
| 158 | Hypothermia (HP:0002045) | 1.78656760 |
| 159 | Hyperlipoproteinemia (HP:0010980) | 1.78165124 |
| 160 | Tubulointerstitial abnormality (HP:0001969) | 1.78136950 |
| 161 | Hypercholesterolemia (HP:0003124) | 1.77911048 |
| 162 | Nephritis (HP:0000123) | 1.77566815 |
| 163 | Abnormal hair laboratory examination (HP:0003328) | 1.76945741 |
| 164 | Palmoplantar hyperkeratosis (HP:0000972) | 1.76764059 |
| 165 | Abnormality of nucleobase metabolism (HP:0010932) | 1.76699446 |
| 166 | Systemic lupus erythematosus (HP:0002725) | 1.76664558 |
| 167 | Palmar hyperkeratosis (HP:0010765) | 1.76628386 |
| 168 | Entropion (HP:0000621) | 1.76424983 |
| 169 | Breast hypoplasia (HP:0003187) | 1.75803252 |
| 170 | Cholelithiasis (HP:0001081) | 1.75503154 |
| 171 | Hypoalphalipoproteinemia (HP:0003233) | 1.75467273 |
| 172 | Leukocytosis (HP:0001974) | 1.75411161 |
| 173 | Chronic hepatic failure (HP:0100626) | 1.75286551 |
| 174 | Abnormality of the renal collecting system (HP:0004742) | 1.74744166 |
| 175 | Microcytic anemia (HP:0001935) | 1.74278815 |
| 176 | Abnormal gallbladder morphology (HP:0012437) | 1.74179774 |
| 177 | Abnormality of iron homeostasis (HP:0011031) | 1.72517560 |
| 178 | Myocardial infarction (HP:0001658) | 1.72465573 |
| 179 | 11 pairs of ribs (HP:0000878) | 1.72047935 |
| 180 | Ectopic kidney (HP:0000086) | 1.71551450 |
| 181 | Poikiloderma (HP:0001029) | 1.71066259 |
| 182 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.71064548 |
| 183 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.71064548 |
| 184 | Abnormal protein glycosylation (HP:0012346) | 1.71064548 |
| 185 | Abnormal glycosylation (HP:0012345) | 1.71064548 |
| 186 | Microretrognathia (HP:0000308) | 1.70446320 |
| 187 | Pulmonary fibrosis (HP:0002206) | 1.70283706 |
| 188 | Thrombophlebitis (HP:0004418) | 1.64540345 |
| 189 | Congenital stationary night blindness (HP:0007642) | 1.61131281 |
| 190 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.60717792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.55546216 |
| 2 | WEE1 | 3.25804597 |
| 3 | NME2 | 2.88003472 |
| 4 | STK16 | 2.38179821 |
| 5 | BUB1 | 2.36665180 |
| 6 | EIF2AK1 | 2.25054064 |
| 7 | IRAK3 | 2.23058832 |
| 8 | EPHA2 | 2.11210209 |
| 9 | IRAK4 | 2.09713920 |
| 10 | PBK | 2.04638294 |
| 11 | MAP3K2 | 2.00920885 |
| 12 | PIM2 | 1.98064041 |
| 13 | CDC7 | 1.87891225 |
| 14 | AKT3 | 1.86332566 |
| 15 | BLK | 1.86175536 |
| 16 | MAP4K2 | 1.84925912 |
| 17 | SRPK1 | 1.84345883 |
| 18 | KIT | 1.84043518 |
| 19 | NEK2 | 1.79481245 |
| 20 | WNK4 | 1.74913827 |
| 21 | LATS1 | 1.74868361 |
| 22 | BRSK2 | 1.73359757 |
| 23 | MAP2K3 | 1.71684760 |
| 24 | MKNK1 | 1.70634845 |
| 25 | FER | 1.68926578 |
| 26 | MAP4K1 | 1.68538850 |
| 27 | PDK2 | 1.67988613 |
| 28 | TEC | 1.64919774 |
| 29 | MKNK2 | 1.59512480 |
| 30 | EIF2AK3 | 1.56726659 |
| 31 | PIM1 | 1.56269346 |
| 32 | CDK7 | 1.54236466 |
| 33 | MAP3K14 | 1.51485421 |
| 34 | ACVR1B | 1.49842972 |
| 35 | BMPR1B | 1.48722096 |
| 36 | EIF2AK2 | 1.47939039 |
| 37 | EEF2K | 1.47013679 |
| 38 | ADRBK2 | 1.46806141 |
| 39 | RPS6KA4 | 1.43474588 |
| 40 | MST1R | 1.43118873 |
| 41 | TTK | 1.42589297 |
| 42 | PLK4 | 1.42526073 |
| 43 | ZAK | 1.42084268 |
| 44 | BMPR2 | 1.41946883 |
| 45 | PINK1 | 1.38795428 |
| 46 | BTK | 1.37202534 |
| 47 | TXK | 1.34223064 |
| 48 | ATR | 1.33637304 |
| 49 | TAOK3 | 1.31515840 |
| 50 | RPS6KB2 | 1.30815055 |
| 51 | WNK3 | 1.30071356 |
| 52 | TGFBR2 | 1.28854299 |
| 53 | CDK4 | 1.28462059 |
| 54 | IKBKB | 1.28387477 |
| 55 | PLK1 | 1.27130917 |
| 56 | AURKB | 1.25283230 |
| 57 | CDK12 | 1.24272965 |
| 58 | TYK2 | 1.24174295 |
| 59 | STK10 | 1.23904882 |
| 60 | STK4 | 1.23354682 |
| 61 | NEK1 | 1.23220734 |
| 62 | JAK3 | 1.22909329 |
| 63 | ZAP70 | 1.21465614 |
| 64 | VRK1 | 1.19483013 |
| 65 | MAP3K4 | 1.18398796 |
| 66 | TSSK6 | 1.13140000 |
| 67 | GRK1 | 1.12194605 |
| 68 | NEK9 | 1.11613270 |
| 69 | PRKAA2 | 1.11499528 |
| 70 | TBK1 | 1.10343305 |
| 71 | TLK1 | 1.07934872 |
| 72 | STK38L | 1.05466731 |
| 73 | ERBB3 | 1.01032178 |
| 74 | DYRK3 | 0.98621273 |
| 75 | IKBKE | 0.95523816 |
| 76 | MATK | 0.93983431 |
| 77 | CDK6 | 0.93578535 |
| 78 | PAK4 | 0.91207897 |
| 79 | FLT3 | 0.91143911 |
| 80 | MAPK11 | 0.90903703 |
| 81 | CHEK2 | 0.86948486 |
| 82 | STK39 | 0.85505796 |
| 83 | CHUK | 0.83469127 |
| 84 | RIPK4 | 0.83153607 |
| 85 | IRAK1 | 0.82143996 |
| 86 | LYN | 0.79471397 |
| 87 | MAPK13 | 0.79076646 |
| 88 | MAP3K8 | 0.77155633 |
| 89 | PRKAA1 | 0.76481650 |
| 90 | CSF1R | 0.75849935 |
| 91 | PASK | 0.75242763 |
| 92 | BCKDK | 0.73764404 |
| 93 | CAMK1G | 0.73388478 |
| 94 | PIK3CG | 0.72711342 |
| 95 | YES1 | 0.71296033 |
| 96 | RPS6KB1 | 0.71001288 |
| 97 | RAF1 | 0.70728110 |
| 98 | CDK8 | 0.68610794 |
| 99 | CLK1 | 0.68544264 |
| 100 | SCYL2 | 0.68212931 |
| 101 | STK3 | 0.67255348 |
| 102 | SYK | 0.67001929 |
| 103 | TGFBR1 | 0.66853535 |
| 104 | ERBB4 | 0.65757231 |
| 105 | MET | 0.63008791 |
| 106 | MAP2K1 | 0.62568972 |
| 107 | MAPKAPK5 | 0.62449733 |
| 108 | FGFR3 | 0.62379396 |
| 109 | KDR | 0.61366161 |
| 110 | MAP3K6 | 0.60666305 |
| 111 | CHEK1 | 0.60366755 |
| 112 | LCK | 0.59836148 |
| 113 | TRPM7 | 0.59251260 |
| 114 | ATM | 0.58793133 |
| 115 | PLK3 | 0.58544436 |
| 116 | NUAK1 | 0.57348867 |
| 117 | JAK2 | 0.56973076 |
| 118 | CSNK2A1 | 0.56428137 |
| 119 | ABL2 | 0.56320716 |
| 120 | MAP3K11 | 0.55067492 |
| 121 | HCK | 0.54475416 |
| 122 | JAK1 | 0.52485411 |
| 123 | BRD4 | 0.51972885 |
| 124 | INSRR | 0.51933143 |
| 125 | MAP3K3 | 0.51668418 |
| 126 | CSK | 0.51076213 |
| 127 | PIK3CA | 0.51065417 |
| 128 | CSNK2A2 | 0.50213632 |
| 129 | AURKA | 0.49639180 |
| 130 | MAPKAPK3 | 0.49338549 |
| 131 | ICK | 0.48166183 |
| 132 | PRKACG | 0.47795063 |
| 133 | CAMK1D | 0.47665587 |
| 134 | BRSK1 | 0.47342193 |
| 135 | ERN1 | 0.47044289 |
| 136 | PRKCE | 0.46431471 |
| 137 | RPS6KA6 | 0.46043637 |
| 138 | CCNB1 | 0.45582448 |
| 139 | CDK2 | 0.44107772 |
| 140 | MST4 | 0.43725723 |
| 141 | RPS6KA5 | 0.43725362 |
| 142 | ABL1 | 0.42929454 |
| 143 | RPS6KC1 | 0.40894393 |
| 144 | WNK1 | 0.40743432 |
| 145 | PLK2 | 0.40718632 |
| 146 | BCR | 0.39949511 |
| 147 | ERBB2 | 0.38362853 |
| 148 | CAMKK2 | 0.37760556 |
| 149 | KSR2 | 0.37682521 |
| 150 | CSNK1E | 0.35756228 |
| 151 | IGF1R | 0.35437381 |
| 152 | OXSR1 | 0.35076258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.89281249 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.24606030 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.97345393 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.91662202 |
| 5 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.71724491 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.70657427 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.69652580 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.65603376 |
| 9 | Retinol metabolism_Homo sapiens_hsa00830 | 2.59580737 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.57250458 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.39144241 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.34931467 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28377132 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 2.12416523 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07667392 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02754930 |
| 17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.00062967 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.97128846 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.93490486 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.92351531 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91025037 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90117474 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.87124597 |
| 24 | Proteasome_Homo sapiens_hsa03050 | 1.85721583 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.83489559 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.79809938 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.77569248 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.77055453 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.76501492 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76464056 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.69957301 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.56455704 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.55219178 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52397265 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.46296658 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46074052 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.43850800 |
| 38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.43338463 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.40620073 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38424951 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35780794 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34433846 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32516554 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32209295 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31780345 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30658856 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.23670861 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22417745 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21177574 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.20771145 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18964331 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18800804 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18621696 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.17123677 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15250265 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15106041 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14909947 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13829678 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12903522 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12722602 |
| 61 | Measles_Homo sapiens_hsa05162 | 1.12653339 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10310140 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07756026 |
| 64 | RNA degradation_Homo sapiens_hsa03018 | 1.06450643 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 1.06398573 |
| 66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06307735 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06131120 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05243375 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02791612 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99889347 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99042557 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97066798 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94906674 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92946120 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90927146 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.89621817 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.89589489 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88909889 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.88329882 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.87762557 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86103727 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85142974 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82309735 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.80868039 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80596568 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.79879872 |
| 87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79799265 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79198227 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.76702388 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.76676824 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76115371 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74648986 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73682181 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.73130170 |
| 95 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73061041 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71906224 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70480608 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.68861984 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68681232 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.68447626 |
| 101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68072380 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67196127 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66507022 |
| 104 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65802094 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65092670 |
| 106 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64554815 |
| 107 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63544974 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63533956 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63003690 |
| 110 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62463157 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61384886 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61081259 |
| 113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60088174 |
| 114 | Allograft rejection_Homo sapiens_hsa05330 | 0.59695913 |
| 115 | Tuberculosis_Homo sapiens_hsa05152 | 0.59636551 |
| 116 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57991182 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57709108 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55334664 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.54478134 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54182700 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53508419 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53111016 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51856455 |
| 124 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.51502308 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51260582 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.50525574 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47519129 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46425848 |
| 129 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46160628 |
| 130 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45535714 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.45003333 |
| 132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44634028 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42938245 |
| 134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42604239 |
| 135 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40697611 |
| 136 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39622092 |
| 137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38804792 |
| 138 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38624070 |
| 139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37381463 |
| 140 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37061416 |
| 141 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37029960 |
| 142 | Hepatitis C_Homo sapiens_hsa05160 | 0.36523381 |
| 143 | ABC transporters_Homo sapiens_hsa02010 | 0.36260756 |
| 144 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35798265 |
| 145 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35774075 |
| 146 | Phototransduction_Homo sapiens_hsa04744 | 0.33684860 |
| 147 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33420756 |
| 148 | Alcoholism_Homo sapiens_hsa05034 | 0.27641329 |
| 149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25175142 |
| 150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24720889 |
| 151 | Mineral absorption_Homo sapiens_hsa04978 | 0.15476636 |
| 152 | Protein export_Homo sapiens_hsa03060 | 0.13122114 |
| 153 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.10879791 |

